Paper23001043
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S and 9 others. Oncogene, 2013. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Papers, record 23001043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23001043
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Proto-Oncogene Proteins c-fos | Major topic |
| 3' Untranslated Regions | |
| Animals | |
| Base Pairing | |
| Base Sequence | |
| Cell Line, Tumor | |
| Cell Movement | |
| Female | |
| Gene Expression | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Lymphatic Metastasis | |
| Mice | |
| Neoplasm Invasiveness | |
| Neoplasm Metastasis | |
| Fos-Related Antigen 1 |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21240262 | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. | Nat Med | 2011 | https://conductscience.org/library/papers/21240262 | PubMed |
| 2 | 19461653 | The miR-34 family in cancer and apoptosis. | Cell Death Differ | 2010 | https://conductscience.org/library/papers/19461653 | PubMed |
| 3 | 18948893 | MicroRNA-10b and breast cancer metastasis. | Nature | 2008 | https://conductscience.org/library/papers/18948893 | PubMed |
| 4 | 14973191 | Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/14973191 | PubMed |
| 5 | 22074923 | MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22074923 | PubMed |
| 6 | 21692045 | miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. | Cancer | 2011 | https://conductscience.org/library/papers/21692045 | PubMed |
| 7 | 22020437 | miR-34 miRNAs provide a barrier for somatic cell reprogramming. | Nat Cell Biol | 2011 | https://conductscience.org/library/papers/22020437 | PubMed |
| 8 | 19524507 | A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. | Cell | 2009 | https://conductscience.org/library/papers/19524507 | PubMed |
| 9 | 20736365 | Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. | Cancer Res | 2010 | https://conductscience.org/library/papers/20736365 | PubMed |
| 10 | 10451706 | Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. | Genes Chromosomes Cancer | 1999 | https://conductscience.org/library/papers/10451706 | PubMed |
| 11 | 21831840 | Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21831840 | PubMed |
| 12 | 11431356 | Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. | Cancer Res | 2001 | https://conductscience.org/library/papers/11431356 | PubMed |
| 13 | 17898713 | Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. | Nature | 2007 | https://conductscience.org/library/papers/17898713 | PubMed |
| 14 | 21814748 | Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21814748 | PubMed |
| 15 | 22085528 | miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. | Chin J Cancer | 2011 | https://conductscience.org/library/papers/22085528 | PubMed |
| 16 | 19262572 | MicroRNAs--the micro steering wheel of tumour metastases. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19262572 | PubMed |
| 17 | 18406353 | Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18406353 | PubMed |
| 18 | 18519671 | Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Cancer Res | 2008 | https://conductscience.org/library/papers/18519671 | PubMed |
| 19 | 12778135 | The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12778135 | PubMed |
| 20 | 10502734 | Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10502734 | PubMed |
Cited by136
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967165 | Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation. | Onco Targets Ther | 2026 | https://conductscience.org/library/papers/42967165 | PubMed |
| 42882513 | Aberrant Transcription-Factor Expression and Regulatory microRNAs in Metastatic Breast Cancer. | Cells | 2026 | https://conductscience.org/library/papers/42882513 | PubMed |
| 41059335 | FRA1 (FOSL1) suppresses neoplastic transformation and modulates radiation responses via transcriptional control of mitogenic and stress-responsive networks. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41059335 | PubMed |
| 40144339 | Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40144339 | PubMed |
| 39795985 | Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39795985 | PubMed |
| 39006295 | Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39006295 | PubMed |
| 38802812 | Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38802812 | PubMed |
| 38791400 | FOSL1's Oncogene Roles in Glioma/Glioma Stem Cells and Tumorigenesis: A Comprehensive Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791400 | PubMed |
| 38616694 | Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer. | Tuberc Respir Dis (Seoul) | 2024 | https://conductscience.org/library/papers/38616694 | PubMed |
| 38303867 | MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway. | J Dent Sci | 2024 | https://conductscience.org/library/papers/38303867 | PubMed |
| 37965449 | Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | https://conductscience.org/library/papers/37965449 | PubMed |
| 37962808 | Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein. | Cell Oncol (Dordr) | 2024 | https://conductscience.org/library/papers/37962808 | PubMed |
| 37835417 | MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835417 | PubMed |
| 37833709 | Intelligent identification system of gastric stromal tumors based on blood biopsy indicators. | BMC Med Inform Decis Mak | 2023 | https://conductscience.org/library/papers/37833709 | PubMed |
| 37686617 | Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686617 | PubMed |
| 37259089 | EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? | Mol Cancer | 2023 | https://conductscience.org/library/papers/37259089 | PubMed |
| 37176013 | FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176013 | PubMed |
| 37083075 | Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer. | Int J Oncol | 2023 | https://conductscience.org/library/papers/37083075 | PubMed |
| 36032067 | The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases. | Front Immunol | 2022 | https://conductscience.org/library/papers/36032067 | PubMed |
| 35961977 | A miR-34a-guided, tRNAiMet-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of breast cancer cells via targeting PFKFB3. | Cell Death Discov | 2022 | https://conductscience.org/library/papers/35961977 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOSL1 | 8061 | PubTator's text mining | https://conductscience.org/library/genes/8061 | NCBI Gene |
| MIR34A | 407040 | PubTator's text mining | https://conductscience.org/library/genes/407040 | NCBI Gene |
| MIR34C | 407042 | PubTator's text mining | https://conductscience.org/library/genes/407042 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23001043
GET https://conductscience.org/api/papers/v1/23001043/references?page=2